CMT DEPLOY: Accelerating Treatments. Together.

Driving a global movement to fast-track treatments for Charcot-Marie-Tooth disease.

What Is CMT DEPLOY?

CMT DEPLOY is a bold, coordinated initiative designed to remove every roadblock in the way of treatments and cures for Charcot-Marie-Tooth disease.

From patient registries and clinical trial training to wearable tech and biomarker discovery, DEPLOY brings together patients, care partners, advocacy leaders, researchers, biopharma, and regulators under one shared mission.

Why It Matters

❌ Trials failing due to poor clinical trial design and/or missing data

✅ Clean, real-time data and tools built from CMT patient voices

❌ Patients excluded or underrepresented

✅ Inclusive design with real-world input & execution

❌ Years lost waiting

✅ Progress measured in months, not decades

❌ Misaligned, siloed, and unpublished studies & failed trials

✅ Aggregated & analyzed data for quality control, and regulatory alignment

“Even the best therapies can fail without clean data, jeopardizing breakthroughs and delaying progress.”

What’s Next: Deploying With Urgency

Stage 1: Launch Consortium & Study

Stage 2: Create CMT Data Warehouse

Stage 3: Regulatory submission for tools + trial integration

Take Action and Deploy with Us!

Download Brochure

Book a Call with HNF Team

“Fueled by urgency and aligned with industry momentum, HNF doesn’t wait.”
Princeton Healthcare Strategies

Our most recent TRIAD partnerships & initiatives

HNF participates and supports an advocacy role by providing real-world data to the FDA and other stakeholders. Our critical data facilitates improved knowledge of the lived experience of CMT patients and the advancement of clinical development.